Cloning natural product biosynthetic gene clusters from cultured or uncultured sources and their subsequent expression by genetically tractable heterologous hosts is an essential strategy for the elucidation and characterisation of novel microbial natural products. The availability of suitable expression hosts is a critical aspect of this workflow. In this work, we mutagenised five endogenous biosynthetic gene clusters from Streptomyces albus S4, which reduced the complexity of chemical extracts generated from the strain and eliminated antifungal and antibacterial bioactivity. We showed that the resulting quintuple mutant can express foreign biosynthetic gene clusters by heterologously producing actinorhodin, cinnamycin and prunustatin. We ...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Streptomycetes are known for their inherent ability to produce pharmaceutically relevant secondary m...
Abstract Background Genome sequencing revealed that Streptomyces sp. can dedicate up to ~ 10% of the...
BACKGROUND: Heterologous expression of secondary metabolite gene clusters is used to achieve incr...
Streptomyces spp. are robust producers of medicinally-, industrially- and agriculturally-important s...
AbstractMicrobial-derived natural products are important in both the pharmaceutical industry and aca...
The rise in antimicrobial resistance combined with the decline in antibiotic discovery has put antib...
Natural products are an important source of novel investigational compounds in drug discovery. Espe...
Streptomyces albus J1074 is recognized as an effective host for heterologous production of natural p...
Streptomyces genomes encode numerous gene clusters able to synthesize secondary metabolites with pot...
Streptomyces lividans is a suitable host for the heterologous expression of biosynthetic gene cluste...
Abstract Background The Streptomyces albus J1074 strain is one of the most widely used chassis for t...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Streptomycetes are known for their inherent ability to produce pharmaceutically relevant secondary m...
Abstract Background Genome sequencing revealed that Streptomyces sp. can dedicate up to ~ 10% of the...
BACKGROUND: Heterologous expression of secondary metabolite gene clusters is used to achieve incr...
Streptomyces spp. are robust producers of medicinally-, industrially- and agriculturally-important s...
AbstractMicrobial-derived natural products are important in both the pharmaceutical industry and aca...
The rise in antimicrobial resistance combined with the decline in antibiotic discovery has put antib...
Natural products are an important source of novel investigational compounds in drug discovery. Espe...
Streptomyces albus J1074 is recognized as an effective host for heterologous production of natural p...
Streptomyces genomes encode numerous gene clusters able to synthesize secondary metabolites with pot...
Streptomyces lividans is a suitable host for the heterologous expression of biosynthetic gene cluste...
Abstract Background The Streptomyces albus J1074 strain is one of the most widely used chassis for t...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Streptomycetes are known for their inherent ability to produce pharmaceutically relevant secondary m...